Ophthalmology

Top Story

BLOG: Premium lenses in patients with maculopathy: Blasphemy?

August 17, 2018

Iridex posts $3.3 million net loss in second quarter

August 17, 2018
Iridex reported a net loss of $3.3 million, or $0.28 per share, in the second quarter of 2018 compared with a net loss of $2.75 million, or $0.24 per share, in the…
Meeting NewsVideo

VIDEO: Physician leadership development ‘now more than ever’ imperative

August 17, 2018
AUSTIN, Texas — In this exclusive video perspective from GI Outlook 2018, Karen L. Woods, MD, of Houston Methodist Gastroenterology Associates, discusses her…
Meeting NewsVideo

VIDEO: ASGE works toward movement on MIPS, MACRA

August 17, 2018
AUSTIN, Texas — In this exclusive video perspective from GI Outlook 2018, Steven A. Edmundowicz, MD, FASGE, interim Division Director of Gastroenterology and…

FDA approves Eylea 12-week dosing for wet AMD

August 17, 2018
The FDA has approved a supplemental biologics license application for a 12-week dosing schedule of Eylea injection in wet age-related macular degeneration patients…
More Headlines »
Clinical Science

Predictors of Visual Acuity Outcomes Following Vitrectomy for Idiopathic Macular Hole

Ophthalmic Surgery, Lasers and Imaging Retina, August 2018, Volume 49 Issue 8
To investigate predictors of visual outcomes in patients who underwent vitrectomy for full-thickness macular hole…
More »
CME

Providing Defense at the Ocular Surface: Managing Dry Eye

This activity is supported by an educational grant from Shire.

This CME activity will discuss modalities for diagnosing ocular surface disease as well as assess the attributes and…
More »
Resource Centers
Video
Meeting News

VIDEO: ASGE works toward movement on MIPS, MACRA

August 17, 2018
More »